Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Malaria Clinical Trials

65 recruiting trials for Malaria. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
65
Total Trials
65
Recruiting Now
8
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT07358910

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure...

Sponsor: Institut Pasteur du CambodgeEnrolling: 100001 location
RECRUITINGPhase 4NCT06068530

Mass Vaccine and Drug Administration, Bangladesh

This is an open i.e. not blinded, cluster-randomised, controlled intervention study. The study will use a factorial design to estimate the protective effectiveness of mass drug...

Sponsor: University of OxfordEnrolling: 100002 locations
RECRUITINGPhase 4NCT06624631

PDMC Implementation Trial in Kenya

The goal of this implementation trial is to evaluate at least two alternative delivery strategies and adherence support for malaria chemoprevention with...

Sponsor: Liverpool School of Tropical MedicineEnrolling: 6001 location
RECRUITINGPhase 1NCT06408857

Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population

This study will test a new drug (MAM01) to find which doses are safe and could help prevent people from getting malaria for at least 4 months. The study will take place in parts...

Sponsor: Gates Medical Research InstituteEnrolling: 1232 locations
RECRUITINGNCT07261280

Testing a Biometric Identification System to Improve Malaria Vaccine Completion

Receiving all four doses of the malaria vaccine can significantly protect children against malaria illness, hospitalization, and death. However, in Ghana, only 46% of children...

Sponsor: University of MichiganEnrolling: 47151 location
RECRUITINGPhase 4NCT06860178

Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa

This is a multi-site, multi-disciplinary, Phase-4 two-arm cluster-randomised non-inferiority trial in Burkina Faso and Mali to evaluate the effectiveness and real-life impact of a...

Sponsor: EpicentreEnrolling: 400002 locations
RECRUITINGNCT04083508

Vivax Malaria Human Infection Studies in Thailand

This study is a human challenge study to assess the feasibility and safety of controlled human malaria infection (via P. vivax sporozites) in healthy volunteers, and to develop a...

Sponsor: University of OxfordEnrolling: 61 location
RECRUITINGPhase 1 / Phase 2NCT03375983

Plasmodium Immunotherapy for Advanced Cancers

The purpose of this study is to evaluate the safety of Plasmodium immunotherapy and preliminarily evaluate the effectiveness of Plasmodium immunotherapy for advanced cancers.The...

Sponsor: CAS Lamvac Biotech Co., Ltd.Enrolling: 201 location
RECRUITINGPhase 4NCT05788094

ACT vs CQ With Tafenoquine for P. Vivax Mono-infection

In this area of Greater Mekong Subregion (GMS), vivax malaria is the most common kind of malaria. It can stay very long in the liver, and come out later to make another episode of...

Sponsor: Shoklo Malaria Research UnitEnrolling: 6061 location
RECRUITINGNCT02639299

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria...

Background: Malaria is a serious infection caused by a parasite. People get malaria when an infected mosquito bites them. Malaria can cause major health and social problems in...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 15001 location
RECRUITINGPhase 4NCT04704999

Southeast Asia Dose Optimization of Tafenoquine

Tafenoquine was recently approved by regulatory authorities in the USA and Australia. Tafenoquine is an alternative radical curative treatment to primaquine acting against the...

Sponsor: University of OxfordEnrolling: 7005 locations
RECRUITINGPhase 1NCT06171113

A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

The primary purpose of the study is to characterise the safety of GSK4024484 in healthy participants within a controlled pharmacokinetic (PK) range, and the effect of food on the...

Sponsor: GlaxoSmithKlineEnrolling: 1561 location
RECRUITINGPhase 3NCT06962319

Safety of Antimalarials in the FIRst trimEster

The SAFIRE study aims to find effective treatments with acceptable safety for malaria in early pregnancy, a particularly sensitive time for the adverse consequences of malaria in...

Sponsor: Liverpool School of Tropical MedicineEnrolling: 15103 locations
RECRUITINGNCT06529237

Malaria Molecular Surveillance in Mozambique (Phase 2)

Mozambique is among the ten countries with the highest burden of malaria worldwide, with an estimated 10.3 million cases in 2021. Malaria transmission is highly heterogeneous...

Sponsor: Centro de Investigacao em Saude de ManhicaEnrolling: 187501 location
RECRUITINGPhase 1NCT06958198

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria...

This is a Phase Ib age de-escalation, dose escalation, open-label study to assess the safety and immunogenicity of the multi-stage malaria vaccine candidate R21 plus RH5.1 and/or...

Sponsor: University of OxfordEnrolling: 561 location
RECRUITINGPhase 3NCT06148792

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

The goal of this clinical trial is to assess the efficacy and safety or a revised weight band tafenoquine dose in vivax malaria patients. The main question\[s\] it aims to answer...

Sponsor: Menzies School of Health ResearchEnrolling: 10904 locations
RECRUITINGNCT00001645

Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

The purpose of this study is to evaluate, treat and follow patients with parasitic infections. People with a known or suspected parasitic infection who are at least 1 year old...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 8001 location
RECRUITINGPhase 3NCT06923592

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

The resilience of P. vivax to malaria elimination efforts is due to its ability to form dormant liver stages (hypnozoites) that reactivate weeks to months after the initial...

Sponsor: London School of Hygiene and Tropical MedicineEnrolling: 192002 locations
RECRUITINGPhase 4NCT07468513

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

A non randomized observation study that is aiming to assess the safety and efficacy of high dose primaquine (1mg/kg per day over 7 days) among patients with intermediate (30-70%)...

Sponsor: Menzies School of Health ResearchEnrolling: 1004 locations
RECRUITINGNCT05711485

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

Open-label randomized controlled trial to test the effectiveness of whole blood transfusion for improving survival in children with severe malaria complicated by thrombocytopenia.

Sponsor: Johns Hopkins Bloomberg School of Public HealthEnrolling: 1322 locations
RECRUITINGPhase 3NCT05951595

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and...

The goal of this open-label randomised, controlled, non-inferiority trial is to assess and compare the efficacy, tolerability and safety of a fixed dose TACT...

Sponsor: University of OxfordEnrolling: 16801 location
RECRUITINGPhase 4NCT05757167

Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

The purpose of the INTREPiD study is to compare 1st trimester screening for malaria parasites with a high-sensitivity malaria rapid diagnostic test followed by treatment of...

Sponsor: Duke UniversityEnrolling: 25002 locations
RECRUITINGPhase 2NCT06879327

Infant Malaria Vaccine Schedule Optimization

The aim of this study is to identify an optimal infant vaccine schedule for a malaria vaccine which is better aligned with the timing of other vaccine interventions.

Sponsor: PATHEnrolling: 12002 locations
RECRUITINGNCT02471378

Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates

Background: \- Malaria is a disease that affects many people in African countries. It is caused by germs that are spread by mosquito bites. It can be fatal if not diagnosed and...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 74761 location
RECRUITINGPhase 3NCT06578572

Seasonal R21 Mass Vaccination for Malaria Elimination

This is a cluster randomized trial to determine the impact of seasonal R21/MM mass vaccination (all ages) on malaria transmission and morbidity. Fifty-four villages (30 in The...

Sponsor: London School of Hygiene and Tropical MedicineEnrolling: 162002 locations
RECRUITINGPhase 1 / Phase 2NCT05478720

DON in Pediatric Cerebral Malaria

The goal of this clinical trial is to evaluate the safety of a single intravenous dose of DON in healthy adults, adults with uncomplicated malaria, and children 12 months-14 years...

Sponsor: Douglas Postels, MD, MSEnrolling: 1522 locations
RECRUITINGPhase 4NCT06601712

Post-discharge Malaria Chemoprevention Implementation Trial in Benin

The proposed research aims to conduct implementation trials in Benin, co-designed with national stakeholders, to evaluate different delivery strategies for optimizing health...

Sponsor: Institut de Recherche Clinique du BeninEnrolling: 6482 locations
RECRUITINGNCT07009847

An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

This is an observational case-control study to assess the effectiveness of the R21/Matrix-M vaccine against severe malaria, clinical malaria (in high transmission perennial...

Sponsor: Serum Institute of India Pvt. Ltd.Enrolling: 23085 locations
RECRUITINGNCT07416461

Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease

The goal of this observational study is to learn about the impact of malaria vaccination on the risk of invasive non-typhoidal Salmonella disease in children below the age of 5....

Sponsor: International Vaccine InstituteEnrolling: 100001 location
RECRUITINGPhase 2NCT07060508

L9LS in Women of Childbearing Potential in Mali

Safety and Efficacy of L9LS, a Human Monoclonal Antibody Against Plasmodium falciparum, in a Randomized, Double-Blind, Placebo-Controlled Trial of Women of Childbearing Potential...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 2903 locations
RECRUITINGPhase 3NCT07082205

Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge

Background and rationale: Hospitalised children with severe anaemia remain at high risk of dying or requiring hospital readmission for at least 6 months after discharge. In highly...

Sponsor: Liverpool School of Tropical MedicineEnrolling: 3982 locations
RECRUITINGNCT07269314

Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology

The goal is to develop molecular systems to support or replace in microscopic characterization and in vitro tests with molecular biology systems capable of improving performance...

Sponsor: Fondazione IRCCS Policlinico San Matteo di PaviaEnrolling: 2001 location
RECRUITINGNCT05071079

A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes

The primary objectives of this study are to assess the safety and feasibility of blood-stage controlled human P. vivax malaria infection (CHMI) in healthy adult Thai volunteers...

Sponsor: University of OxfordEnrolling: 481 location
RECRUITINGNCT05041556

Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine

The ongoing Malaria Vaccine Pilot Evaluation (MVPE) is being conducted in Ghana, Malawi and Kenya through community and sentinel hospital surveillance systems and a series of...

Sponsor: Kintampo Health Research Centre, GhanaEnrolling: 92804 locations
RECRUITINGPhase 4NCT07038837

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission...

This is a two-arm, cluster-randomised, phase IV trial conducted in Chad to assess the protective efficacy and impact in real-life conditions of a new strategy for administering...

Sponsor: EpicentreEnrolling: 700001 location
RECRUITINGNCT07257965

Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults

This study is a human challenge study to assess the minimum infective mosquito bite dose in a controlled human malaria Infection (via P. vivax sporozites) in healthy volunteers....

Sponsor: University of OxfordEnrolling: 241 location
RECRUITINGNCT05934318

L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)

There are few safe, effective, and affordable interventions to improve pregnancy outcomes in low resource settings where the highest rates of poor birth outcomes occur....

Sponsor: Liverpool School of Tropical MedicineEnrolling: 29601 location
RECRUITINGPhase 1 / Phase 2NCT04165590

Plasmodium Immunotherapy for Advanced Malignant Solid Tumors

The purpose of this study is: 1) to evaluate the effectiveness and extended safety of the Plasmodium immunotherapy for the advanced malignant solid tumors. 2) To explore the safe...

Sponsor: CAS Lamvac Biotech Co., Ltd.Enrolling: 601 location
RECRUITINGNCT04529434

Star Homes Project 2

Malaria, pneumonia and diarrhoea causes a lot of illness in children in Tanzania and the study want to find better ways of protecting people against these diseases and want to...

Sponsor: University of OxfordEnrolling: 27501 location
RECRUITINGNCT06468319

Pregnancy Registry in Mali

This registry will assess pregnancy outcomes through demographic surveillance and prospective data collection at a health facility in Kalifabougou, Mali.

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 95001 location
RECRUITINGNCT03937817

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Background: Blood disorders like sickle cell disease and malaria affect many people around the world. Researchers want to learn more about blood disorders. To do this, they need...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 3001 location
RECRUITINGPhase 1 / Phase 2NCT03474822

Plasmodium Immunotherapy for Breast and Liver Cancers

The purpose of this study is to evaluate the safety and preliminarily evaluate the effectiveness of Plasmodium immunotherapy for advanced breast cancers and advanced liver...

Sponsor: CAS Lamvac Biotech Co., Ltd.Enrolling: 601 location
RECRUITINGPhase 2 / Phase 3NCT05764746

Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Background: Artemisinin resistance has emerged in parts of Southeast Asia, and there are reports in Africa of reduced susceptibility of Plasmodium falciparum parasites against...

Sponsor: Muhimbili University of Health and Allied SciencesEnrolling: 3842 locations
RECRUITINGNCT07345286

Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC

The epidemiology and outcome of febrile illnesses in the Democratic Republic of Congo (DRC) is poorly documented. The FIKI² study, a prospective observational study of...

Sponsor: Institute of Tropical Medicine, BelgiumEnrolling: 5001 location
RECRUITINGNCT06232954

Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in Uganda

A cluster-randomized double-blinded control trial will be conducted in Uganda to demonstrate and quantify the protective efficacy (PE) of Mossie-GO, an active spatial repellent...

Sponsor: Africa Power LimitedEnrolling: 56001 location
RECRUITINGPhase 2NCT07036159

A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months

The purpose of this study is to evaluate the safety and immunogenicity of reduced antigen doses and alternative vaccination regimes for RTS,S/AS01E in healthy children aged 5-60...

Sponsor: GlaxoSmithKlineEnrolling: 2382 locations
RECRUITINGPhase 3NCT05690841

FocaL Mass Drug Administration for Vivax Malaria Elimination

FLAME is an open-label cluster-randomized controlled trial that aims to determine the effectiveness of focal mass drug administration (fMDA) to reduce the incidence of Plasmodium...

Sponsor: University of California, San FranciscoEnrolling: 75301 location
RECRUITINGPhase 2NCT07147400

Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults

This is a Phase 2, randomized, double-blind, controlled study designed to evaluate the safety, tolerability, immunogenicity, vaccine efficacy, and functional activity of...

Sponsor: Serum Institute of India Pvt. Ltd.Enrolling: 12001 location
RECRUITINGNCT01168271

Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early...

Malaria caused by Plasmodium falciparum continues to be a global problem with devastating consequences. A greater understanding of the immunologic and parasitologic factors...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 150002 locations
RECRUITINGNCT06418256

Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations

Human splenic physiology remains poorly understood due to lack of functional exploration. However, through its ability to recognize alterations or modifications in circulating...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1005 locations

Showing 50 of 65 trials.Search all Malaria trials